MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Monday, March 4, 2019

Celebrate Your Support Partners This March

Join us in thanking the support partners who help empower the multiple sclerosis (MS) community! 

During MS Awareness Month, MS Views and News is excited to once again be working with Biogen and other MS organizations on #MySupportHero – a special way to celebrate those who support us in our journey with MS, be it family, friends, healthcare professionals or advocacy groups who help us rise above MS.

There are multiple ways to show appreciation:

·       Share and repost #MySupportHero posts across social media channels from Above MS, @BiogenMS and MS Views and News Facebook, Twitter and Instagram channels  
      Visit to learn about #MySupportHero and how you can show appreciation for the support partners in your life

Learn more about #MySupportHero, how we’re celebrating support heroes and how you can inspire others to do the same.

Note: Biogen does not have any involvement with content unrelated to #MySupportHero on MS Views and News website and social media pages.


No comments: